American Journal of Cardiology
Volume 104, Issue 12 , Pages 1613-1617 , 15 December 2009

Impact of Prior Statin Therapy on Arrhythmic Events in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE])

  • Ameeth Vedre, MD

      Affiliations

    • Division of Cardiology, Michigan Cardiovascular Outcomes Research and Reporting Program, University of Michigan, Ann Arbor, Michigan
    • Department of Cardiology, Michigan State University, East Lansing, Michigan
    • ,
  • Hitinder S. Gurm, MD

      Affiliations

    • Division of Cardiology, Michigan Cardiovascular Outcomes Research and Reporting Program, University of Michigan, Ann Arbor, Michigan
    • ,
  • James B. Froehlich, MD, MPH

      Affiliations

    • Division of Cardiology, Michigan Cardiovascular Outcomes Research and Reporting Program, University of Michigan, Ann Arbor, Michigan
    • ,
  • Eva Kline-Rogers, RN, MS

      Affiliations

    • Division of Cardiology, Michigan Cardiovascular Outcomes Research and Reporting Program, University of Michigan, Ann Arbor, Michigan
    • ,
  • Gilles Montalescot, MD, PhD

      Affiliations

    • Institute of Cardiology, Centre Hospitalier Universitaire Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
    • ,
  • Joel M. Gore, MD

      Affiliations

    • University of Massachusetts Medical School, Worcester, Massachusetts
    • ,
  • David Brieger, MBBS, PhD

      Affiliations

    • Department of Cardiology, Coronary Care Unit, Concord Hospital, Sydney, Australia
    • ,
  • Ann L. Quill, MA

      Affiliations

    • University of Massachusetts Medical School, Worcester, Massachusetts
    • ,
  • Kim A. Eagle, MD

      Affiliations

    • Division of Cardiology, Michigan Cardiovascular Outcomes Research and Reporting Program, University of Michigan, Ann Arbor, Michigan
    • Corresponding Author InformationCorresponding author: Tel: 734-936-5275; fax: 734-764-4119
    • ,
  • GRACE Investigators

Received 17 April 2009 ,Revised 19 July 2009 ,Accepted 19 July 2009.

References 

  1. Mark D. When innovative therapies make economic sense: economic analysis of enoxaparin versus unfractionated heparin in the ESSENCE trial—an overviewEfficacy and safety of subcutaneous in non-Q wave coronary events. Can J Cardiol. 1998;14(suppl):24E–27E
  2. Pedersen TR, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Faergeman G, et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) (1994). Atheroscler Suppl. 2004;5:81–87
  3. Mehta RH, Dabbous OH, Granger CB, Kuznetsova P, Kline-Rogers EM, Anderson FA, et al. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol. 2003;92:1031–1036
  4. Sotiriou CG, Cheng JW. Beneficial effects of statins in coronary artery disease—beyond lowering cholesterol. Ann Pharmacother. 2000;34:1432–1439
  5. Chen J, Shen H, Nagasawa Y, Mitsui K, Tsurugi K, Hashimoto K. Pravastatin inhibits arrhythmias induced by coronary artery ischemia in anesthetized rats. J Pharmacol Sci. 2007;103:317–322
  6. Chen J, Nagasawa Y, Zhu BM, Ohmori M, Harada K, Fujimura A, et al. Pravastatin prevents arrhythmias induced by coronary artery ischemia/reperfusion in anesthetized normocholesterolemic rats. J Pharmacol Sci. 2003;93:87–94
  7. Rationaledesign of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001;141:190–199
  8. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lopez-Sendon J. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet. 2002;359:373–377
  9. Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002;90:358–363
  10. Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, et al. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006;47:769–773
  11. Humphries KH, Lee M, Sheldon R, Ramanathan K, Dorian P, Green M, et al. Statin use and recurrence of atrial fibrillation after successful cardioversion. Am Heart J. 2007;154:908–913
  12. Ozaydin M, Varol E, Aslan SM, Kucuktepe Z, Dogan A, Ozturk M, et al. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. Am J Cardiol. 2006;97:1490–1493
  13. Fauchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2008;51:828–835
  14. Song YB, On YK, Kim JH, Shin DH, Kim JS, Sung J, et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. Am Heart J. 2008;156:373;e379–e316
  15. Young-Xu Y, Jabbour S, Goldberg R, Blatt CM, Graboys T, Bilchik B, et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol. 2003;92:1379–1383
  16. Hanna IR, Heeke B, Bush H, Brosius L, King-Hageman D, Dudley SC, et al. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm. 2006;3:881–886
  17. Marin F, Pascual DA, Roldan V, Arribas JM, Ahumada M, Tornel PL, et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol. 2006;97:55–60
  18. Adam O, Neuberger HR, Bohm M, Laufs U. Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Circulation. 2008;118:1285–1293
  19. Laufs U. Beyond lipid-lowering: effects of statins on endothelial nitric oxide. Eur J Clin Pharmacol. 2003;58:719–731
  20. Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89–118
  21. Werner N, Nickenig G, Laufs U. Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Res Cardiol. 2002;97:105–116

 The Global Registry of Acute Coronary Events (GRACE) is supported by an educational grant from Sanofi-Aventis, Paris, France.

PII: S0002-9149(09)01476-3

doi: 10.1016/j.amjcard.2009.07.045

American Journal of Cardiology
Volume 104, Issue 12 , Pages 1613-1617 , 15 December 2009

Article Tools

* Image Usage & Resolution